The identification of progression in multiple sclerosis is typically retrospective. Given the
profound burden of progressive multiple sclerosis, and the recent development of effective …

Accumulating neurological disability has a substantial impact on the lives of patients with
multiple sclerosis (MS). As well as the established Expanded Disability Status Scale (EDSS) …

Background: The gold standards for assessing ambulation are the Expanded Disability
Status Scale (EDSS) and the Timed 25-Foot Walk (T25FW) test. In relation with these …

Conversion to secondary progressive (SP) course is the decisive factor for long-term
prognosis in relapsing multiple sclerosis (MS), generally considered the clinical equivalent …

Background and Objectives: In this critical review, we explore the potential use of MRI
measurements as prognostic biomarkers in multiple sclerosis (MS) patients, for both …

Background People with multiple sclerosis (MS), who are often immunocompromised,
require complex care and engage with a variety of health‐care providers to manage their …

Objective To determine the concordance and statistical precision in gait velocity in people
with multiple sclerosis (pwMS), measured with FeetMe®(insoles with pressure and motion …

Background Multiple sclerosis can cause cardiovascular autonomic dysfunction. It is
assumed that is caused by multiple demyelinating plaques localized in the brain stem and …

Background The corpus callosum index (CCI) can be easily and reliably obtained from
conventional magnetic resonance imaging (MRI) and has been proposed as a possible …

The autoimmune disease multiple sclerosis (MS) is characterized by relapses in the majority
of patients. A definitive clinical diagnosis of relapse in MS can be complicated by the …